Cornelis M van Tilburg

23PUBLICATIONS
145CO-AUTHORS
Molecular targetsInfant and child healthGene and molecular therapyPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Oct 14, 2026
Selpercatinib in Pediatric and Adolescent Patients With RET-Altered Solid Tumors: Safety and Efficacy Results From the Phase I/II LIBRETTO-121 Study.

|May 04, 2026
Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis.

|Aug 13, 2025
Cerebrospinal fluid liquid biopsy guides differential diagnosis of relapsed medulloblastoma versus secondary glioma: A case report of a pediatric patient enrolled on a PDGFRA inhibitor trial.

Tom T Fischer, Kendra K Maass, Melanie Schoof

|Jul 31, 2025
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas.

April A Apfelbaum, Eric Morin, Dominik Sturm

|May 07, 2025
Oncogene aberrations drive medulloblastoma progression, not initiation.

Konstantin Okonechnikov, Piyush Joshi, Verena Körber

|Jan 27, 2025
Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.

Leo Mascarenhas, Steven G DuBois, Catherine M Albert

Pageof 4

Frequent Collaborators

12 joint publications

Till Milde

7 joint publications

Stefan M Pfister

7 joint publications

David T W Jones

7 joint publications

Felix Sahm